LUPIN : US FDA CLOSES GOA PLANT INSPECTION WITH FORM 483

• US FDA inspection at Lupin's Goa manufacturing facility conducted from October 19 to October 23, 2026 • Inspection closed with issuance of a Form-483 with one observation • Company will address the observation and respond to the US FDA within the stipulated timeframe • Lupin stated it is committed to cGMP compliance across all facilities

Lupin Limited

Open attachment

← Back to feed